Winst gevend schreef op 23 oktober 2024 10:55:
October 22 at 13:57 GMT.
Earnings Preview Pharming group, 10-24-2024
Pharming Group NV PHAR.OQ expected to post breakeven results a share.
Pharming Group NV is expected to show a rise in quarterly revenue when
it reports results on October 24 for the period ending September 30 2024
The Leiden Zuid-holland-based company is expected to report a 15.4% increase
in revenue to $76.93 million from $66.66 million a year ago,
according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Pharming Group NV is for breakeven results per share.The current average analyst rating on the shares is "strong buy"
and the breakdown of recommendations is
4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months. ?
Wall Street's median 12-month price target for Pharming Group NV is 1.65?,
below? its last closing price of $8.91. ???
This summary was machine generated October 22 at 13:57 GMT.
All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report,
contact Estimates.Support@lseg.com.
For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)